Similar Papers

Paper Title
Journal
Date
Author
Major ABO Incompatibility Significantly Influences the Survival and Outcomes after Allogeneic Hematopoietic Cell Transplantation in Leukemia - CIBMTR Analysis
Guru Subramanian Guru Murthy ... Bronwen E Shaw
Blood | VOL. 138
Guru Subramanian Guru Murthy, et. al.Guru Subramanian Guru Murthy ... Bronwen E Shaw
05 Nov 2021
265: Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation
M Remberger ... A Wikman
Biology of Blood and Marrow Transplantation | VOL. 13
M Remberger, et. al.M Remberger ... A Wikman
25 Jan 2007
Impact of ABO Mismatch on Outcomes of Allogeneic Hematopoietic Stem Cell Recipients: 30 Years of Experience with 1016 Patients
Erden Atilla ... Selami Kocak Toprak
Blood | VOL. 132
Erden Atilla, et. al.Erden Atilla ... Selami Kocak Toprak
29 Nov 2018
ABO Mismatch Status Does Not Influence the Clinical Outcomes in Haploidentical Hematopoeitic Cell Transplantation
Bita Fakhri ... Rizwan Romee
Blood | VOL. 128
Bita Fakhri, et. al.Bita Fakhri ... Rizwan Romee
02 Dec 2016
View more papers

More From: Transplantation and cellular therapy

Paper Title
Journal
Date
Author
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for children with chronic GVHD after Hematopoietic Cell Transplantation.
Saldaña Bj Dávila ... K M Williams
Transplantation and cellular therapy | VOL. -
Saldaña Bj Dávila, et. al.Saldaña Bj Dávila ... K M Williams
22 Jan 2025
Prolonged neurologic symptoms following immune effector cell-associated neurotoxicity syndrome in patients with large B cell lymphoma treated with chimeric antigen receptor-modified T cell therapy.
Luke Maillie ... Daniel J Landsburg
Transplantation and cellular therapy | VOL. -
Luke Maillie, et. al.Luke Maillie ... Daniel J Landsburg
21 Jan 2025
Low Survival Due to Higher Risk of Relapse and Nonrelapse Mortality After Allogeneic HSCT in ATL Compared with AML and ALL.
Shohei Tomori ... Makoto Yoshimitsu
Transplantation and cellular therapy | VOL. -
Shohei Tomori, et. al.Shohei Tomori ... Makoto Yoshimitsu
17 Jan 2025
Refining Risk Stratification for B-cell Precursor Adult Acute Lymphoblastic Leukemia Treated With a Pediatric-inspired Regimen by Combining IKZF1 Deletion and Minimal Residual Disease.
Shiyu Deng ... Hongsheng Zhou
Transplantation and cellular therapy | VOL. -
Shiyu Deng, et. al.Shiyu Deng ... Hongsheng Zhou
09 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.